Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. J. Bispecific T-Cell Engager>G

---

USA. J. Bispecific T-Cell Engager>G's subsections
(*) USA Approval Date: 2023. 08.10
>4 Prior Lines of Therapy>
>binds to CD3 receptor & GPRC5D
Company
Generic Name
TM
TM Web-Site
USA Patent APP Number

USA. J. Bispecific T-Cell Engager>G's products
This section has no products